Related references
Note: Only part of the references are listed.Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma
Nicolas Vigneron et al.
CLINICAL CHEMISTRY (2020)
Transglutaminase-2 facilitates extracellular vesicle-mediated establishment of the metastatic niche
Aparna Shinde et al.
ONCOGENESIS (2020)
Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events
Reza Jafarzadeh-Esfehani et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
The Dynamic Relationship of Breast Cancer Cells and Fibroblasts in Fibronectin Accumulation at Primary and Metastatic Tumor Sites
Sarah Libring et al.
CANCERS (2020)
Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells
Solmaz Khalighfard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer
Jia Wei et al.
JOURNAL OF CANCER (2020)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer
Aparna Shinde et al.
CANCER RESEARCH (2019)
Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study
Hikaru Nakashima et al.
TUMOR BIOLOGY (2019)
Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia
Yi Shen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma
Haijun Sun et al.
CANCER BIOMARKERS (2019)
Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows
Vera Kloten et al.
CLINICAL CHEMISTRY (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Exosome-mediated transfer of miR-1290 promotes cell proliferation and invasion in gastric cancer via NKD1
Jiying Huang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer
Xiangxiang Liu et al.
JOURNAL OF CANCER (2019)
miR-1290 Contributes to Colorectal Cancer Cell Proliferation by Targeting INPP4B
Qingzhu Ma et al.
ONCOLOGY RESEARCH (2018)
Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis
M. Dunaeva et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Autocrine Fibronectin Inhibits Breast Cancer Metastasis
Aparna Shinde et al.
MOLECULAR CANCER RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Droplet digital PCR quantification of miR-1290 as a circulating biomarker for pancreatic cancer
Francesca Tavano et al.
SCIENTIFIC REPORTS (2018)
Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
Jieru Zhou et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer
Aparna Shinde et al.
BREAST CANCER RESEARCH (2018)
Regulation of epithelial-mesenchymal transition and metastasis by TGF-β, P-bodies, and autophagy
Shana D. Hardy et al.
ONCOTARGET (2017)
miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2
Ling Ye et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Comparison of miRNA quantitation by Nanostring in serum and plasma samples
Catherine Foye et al.
PLOS ONE (2017)
Reference miRNAs for colorectal cancer: analysis and verification of current data
E. Danese et al.
SCIENTIFIC REPORTS (2017)
Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer
H. Imaoka et al.
ANNALS OF ONCOLOGY (2016)
Evidence and potential in vivo functions for biofluid miRNAs: From expression profiling to functional testing
Hina Iftikhar et al.
BIOESSAYS (2016)
sMicroRNA-1290 inhibits cells proliferation and migration by targeting FOXA1 in gastric cancer cells
Mengxin Lin et al.
GENE (2016)
MiR-1290 promotes cancer progression by targeting nuclear factor I/X (NFIX) in esophageal squamous cell carcinoma (ESCC)
Yu Mao et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells
Jia Wu et al.
CANCER LETTERS (2013)
MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls
Ang Li et al.
CLINICAL CANCER RESEARCH (2013)
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
Thorarinn Blondal et al.
METHODS (2013)
Plasma Components Affect Accuracy of Circulating Cancer-Related MicroRNA Quantitation
Dong-Ja Kim et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Recovering circulating extracellular or cell-free RNA from bodily fluids
Georgios Tzimagiorgis et al.
CANCER EPIDEMIOLOGY (2011)
Microfluidic-Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic microRNA Signatures in the Sera of Prostate Cancer Patients
Felix Moltzahn et al.
CANCER RESEARCH (2011)
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
Jennifer S. McDonald et al.
CLINICAL CHEMISTRY (2011)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Share Paper
